International Price Index Will Advance Under New CMMI Chief – If It’s Implemented
Executive Summary
Adam Boehler will leave HHS and his post as director of the Center for Medicare and Medicaid Innovation to move to another job in the Administration.
You may also be interested in...
Point-Of-Sale Rebates May Be Added To US Senate Finance Drug Pricing Bill
Legislation clears committee with no major changes. However, the number of Republicans opposing the bill due to concerns over price inflation rebates portend difficulties ahead for a floor vote.
White House Exec Order Will Bring US Parity With Lowest Drug Prices Abroad, Trump Says
Remarks to reporters prompt surprise and confusion among stakeholders and likely reflect the president’s impatience with the pace of regulatory and legislative pricing reforms.
Medicare Part D Payment Model Gives Health Plans More Incentives To Negotiate Lower Drug Prices
Participating plans to share in savings if they stay below spending target for Part D catastrophic phase and repay 10% of any excess spending; CMS also updates its VBID model.